The American Herbal Products Association (AHPA) is presenting a two-day Hemp-CBD Supplement Congress in Denver, CO this August to provide critical input for companies navigating the rapidly evolving legal, regulatory and financial landscapes to manufacture and market dietary supplement products with hemp or hemp-derived ingredients including cannabidiol (CBD). The event features presentations from federal officials, including speakers from the FDA (U.S. Food and Drug Administration) and USDA (U.S. Department of Agriculture) who will provide insights into their agencies’ approach to regulating hemp-CBD and supplements made with these ingredients.
According to the latest research, hemp-CBD sales are projected to surpass $15-20 billion in the U.S. by 2024, indicating an immediate need for manufacturers and retailers to understand the role of hemp in the dietary supplement category.
“The U.S. market for hemp-derived CBD in dietary supplements is growing and evolving rapidly and companies that manufacture and sell CBD supplements face a host of challenges and opportunities. AHPA’s Congress will provide companies with the information needed to successfully navigate challenges and take advantage of opportunities,” said AHPA President Michael McGuffin. “FDA and USDA officials will join legal and industry experts to provide compliance strategies for dietary supplement regulatory requirements to help companies meet the growing consumer demand for high-quality, safe products.”
AHPA’s Hemp-CBD Congress features a full-day of presentations and discussions on Friday, August 16 and two, half-day workshops on Thursday, August 15 that will cover:
- How to comply with FDA’s current good manufacturing practice (cGMP) requirements for dietary supplements – training by EAS Consulting Group.
- New dietary ingredient (NDI) notifications and generally recognized as safe (GRAS) for hemp as a food additive and dietary ingredient – presented by AIBMR Life Sciences.
Industry experts and government officials will present on a host of issues impacting hemp-CBD companies, including:
- Getting to Market: Hemp Supply Chain Management
- Overcoming Regulatory Obstacles: Updates from the FDA, USDA and Individual States
- Primer on FDA Regulation of Hemp-CBD Supplements
- The Hemp-CBD Supplement Market: A Financial Snapshot
- Hemp-CBD Supplements from the Retailers’ Perspective
Notable sessions include a presentation from USDA Agricultural Marketing Service (AMS) senior marketing specialist William Richmond, who will provide an update on USDA efforts related to the recent decriminalization of hemp. In addition, the FDA will provide an update on the agency’s ongoing efforts to design and implement a regulatory framework to ensure informed access to safe, legal products. This session is sponsored by Greenspoon Marder LLP and will be moderated by Jessica Wasserman, a partner in the International, Government Relations and Cannabis Law practice.
For more information, visit www.ahpa.org.
